Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection

Journal of Clinical Virology

Volumn 58, Issue 4, 2013, Pages 635-640

  Chagan Yasutan, Haorile ^a,b   Ndhlovu, Lishomwa C ^c   Lacuesta, Talitha Lea ^d   Kubo, Toru ^e   Leano, Prisca Susan A ^f   Niki, Toshiro ^g   Oguma, Shigeru ^h   Morita, Kouichi ^e   Chew, Glen M ^c   Barbour, Jason D ^c   Telan, Elizabeth Freda O ^f   Hirashima, Mitsuomi ^g   Hattori, Toshio ^a,b   Dimaano, Efren M ^d  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF HAWAII   (United States)

^d San Lazaro Hospital   (Philippines)

^e NAGASAKI UNIVERSITY   (Japan)

^f National Reference Laboratory for HIV/AIDS Hepatitis and Other STDs   (Philippines)

^g KAGAWA UNIVERSITY   (Japan)

^h TAKEDA GENERAL HOSPITAL   (Japan)

Author keywords

Biomarker; Dengue fever; Dengue hemorrhagic fever; Dengue virus; Galectin 9

Indexed keywords

ALPHA2 INTERFERON; ECALECTIN; EOTAXIN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL FEATURE; CONTROLLED STUDY; CRITICAL ILLNESS; DENGUE; DENGUE VIRUS; GENE DOSAGE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MONOCYTE; PHILIPPINES; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT; VIRUS LOAD;

BIOMARKER; DENGUE FEVER; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; GALECTIN-9;

ACUTE DISEASE; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; DENGUE; EPIDEMICS; GALECTINS; HUMANS; PHILIPPINES; YOUNG ADULT;

EID: 84888836709     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.10.022     Document Type: Article

References (30)

1. Bhatt S., Gething P.W., Brady O.J., Messina J.P., Farlow A.W., Moyes C.L., et al. The global distribution and burden of dengue. Nature 2013, 496:504-507.
2. Nathan M.B., Dayal-Drager R., Guzman M. Epidemiology, burden of disease and transmission. Dengue, guidelines for diagnosis, treatment, prevention and control new edition 2009, 3-21. World Health Organization, Geneva.
3. Simmons C.P., Farrar J.J., Nguyen v.V., Wills B. Dengue. N Engl J Med 2012, 366:1423-1432.
4. Trung D.T., Thao le T.T., Dung N.M., Ngoc T.V., Hien T.T., Chau N.V., et al. Clinical features of dengue in a large Vietnamese cohort: intrinsically lower platelet counts and greater risk for bleeding in adults than children. PLoS Negl Trop Dis 2012, 6:e1679.
5. Martina B.E., Koraka P., Osterhaus A.D. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 2009, 22:564-581.
6. Appanna R., Wang S.M., Ponnampalavanar S.A., Lum L.C., Sekaran S.D. Cytokine factors present in dengue patient sera induces alterations of junctional proteins in human endothelial cells. Am J Trop Med Hyg 2012, 87:936-942.
7. Becquart P., Wauquier N., Nkoghe D., Ndjoyi-Mbiguino A., Padilla C., Souris M., et al. Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production. BMC Infect Dis 2010, 10:356.
8. Guerrero C.D., Arrieta A.F., Ramirez N.D., Rodriguez L.S., Vega R., Bosch I., et al. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. Cytokine 2013, 61:766-771.
9. Vasta G.R., Ahmed H., Nita-Lazar M., Banerjee A., Pasek M., Shridhar S., et al. Galectins as self/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox. Front Immunol 2012, 3:199.
10. Matsumoto R., Matsumoto H., Seki M., Hata M., Asano Y., Kanegasaki S., et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998, 273:16976-16984.
11. Tureci O., Schmitt H., Fadle N., Pfreundschuh M., Sahin U. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 1997, 272:6416-6422.
12. Chabot S., Kashio Y., Seki M., Shirato Y., Nakamura K., Nishi N., et al. Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 2002, 12:111-118.
13. Warke R.V., Xhaja K., Martin K.J., Fournier M.F., Shaw S.K., Brizuela N., et al. Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol 2003, 77:11822-11832.
14. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318:1141-1143.
15. Mengshol J.A., Golden-Mason L., Arikawa T., Smith M., Niki T., McWilliams R., et al. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS ONE 2010, 5:e9504.
16. Chagan-Yasutan H., Shiratori B., Siddiqi U.R., Saitoh H., Ashino Y., Arikawa T., et al. The increase of plasma galectin-9 in a patient with insulin allergy: a case report. Clin Mol Allergy 2010, 8:12.
17. Chagan-Yasutan H., Saitoh H., Ashino Y., Arikawa T., Hirashima M., Li S., et al. Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. Tohoku J Exp Med 2009, 218:285-292.
18. Saitoh H.A.Y., Chagan-Yasutan H., Niki T., Hirashima M., Hattori T. Rapid decrease of plasma galectin-9 levels in patient with acute HIV infection after therapy. Tohoku J Exp Med 2012, 228:157-161.
19. WHO Dengue haemorrhagic fever-diagnosis, treatment, prevention and control 1997, World Health Organization.
20. Masuzawa T., Dancel L.A., Miyake M., Yanagihara Y. Serological analysis of human leptospirosis in the Philippines. Microbiol Immunol 2001, 45:93-95.
21. Vaughn D.W., Nisalak A., Solomon T., Kalayanarooj S., Dung N.M., Kneen R., et al. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 1999, 60:693-698.
22. Parida M., Horioke K., Ishida H., Dash P.K., Saxena P., Jana A.M., et al. Rapid detection and differentiation of dengue virus serotypes by a real-time reverse transcription-loop-mediated isothermal amplification assay. J Clin Microbiol 2005, 43:2895-2903.
23. Kubo T., Agoh M., Mai le Q., Fukushima K., Nishimura H., Yamaguchi A., et al. Development of a reverse transcription-loop-mediated isothermal amplification assay for detection of pandemic (H1N1) 2009 virus as a novel molecular method for diagnosis of pandemic influenza in resource-limited settings. J Clin Microbiol 2010, 48:728-735.
24. Warrilow D., Northill J.A., Pyke A., Smith G.A. Single rapid TaqMan fluorogenic probe based PCR assay that detects all four dengue serotypes. J Med Virol 2002, 66:524-528.
25. Garg A.D., Krysko D.V., Verfaillie T., Kaczmarek A., Ferreira G.B., Marysael T., et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012, 31:1062-1079.
26. Manaloto C.R., Hayes C.G. Isolation of dengue viruses from hospitalized patients in the Philippines, 1983-1986. Southeast Asian J Trop Med Public Health 1989, 20:541-547.
27. Matsuura A., Tsukada J., Mizobe T., Higashi T., Mouri F., Tanikawa R., et al. Intracellular galectin-9 activates inflammatory cytokines in monocytes. Genes Cells 2009, 14:511-521.
28. Sato S., Nieminen J. Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity. Glycoconj J 2004, 19:583-591.
29. Furuta T., Murao L.A., Lan N.T., Huy N.T., Huong V.T., Thuy T.T., et al. Association of mast cell-derived VEGF and proteases in Dengue shock syndrome. PLoS Negl Trop Dis 2012, 6:1505e.
30. Stacey A.R., Norris P.J., Qin L., Haygreen E.A., Taylor E., Heitman J., et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009, 83:3719-3733.